Schedule 13G ownership disclosure

Cytek Biosciences Inc

Security class unavailable · CUSIP: 23285D109

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
14,835,215
Percent of class
10.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001306550-23-009134
Form type
SC 13G/A
Filer
BlackRock Finance, Inc.
CIK
CIK 1364742
Filed
May 05, 2023
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub